Cannabidiorcin (CBDO) 1mg

SKU:
CAY-10006804-1mg
  • $37.00

    • Description

    Cannabidiorcin (CBDO) 1mg

    Product Description

    Abnormal cannabidiol is a synthetic regioisomer of cannabidiol that fails to elicit either central cannabinoid (CB1) or peripheral cannabinoid (CB2) receptors responsiveness and is without psychotropic activity. It induces endothelium-dependent vasodilation via a CB1/CB2/nitric oxide-independent mechanism. O-1821 is a cannabidiol analog with close structural similarity to O-1918 which is a selective antagonist of abnormal cannabidiol at the non-central cannabinoid (CB1)/peripheral cannabinoid (CB2) receptors endothelial receptor. O-1918 does not bind to CB1 or CB2 receptors at concentrations up to 30 µM and inhibits the vasorelaxant effects of abnormal cannabidiol in vitro and in whole animals. The biological activity of O-1821 has not been reported.

    WARNING This product is not for human or veterinary use.

    Technical Information
    Formal Name
    5-methyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol
    CAS Number
    35482-50-9
    Synonyms
    • Cannabidiorcin
    • Cannabidiorcol
    • Cannabidiorocol
    • CBD-C1
    • CBDO
    Molecular Formula
    C17H22O2
    Formula Weight
    258.4
    Purity
    ≥97%
    A solution in acetonitrile
    Solubility
    • DMF: 30 mg/ml
    • DMSO: 30 mg/ml
    • Ethanol: 30 mg/ml
    • Ethanol:PBS (pH 7.2)(1:1): .5 mg/ml
    λmax
    208, 281 nm
    SMILES
    CC1=C[C@@H](C2=C(O)C=C(C)C=C2O)[C@H](C(C)=C)CC1
    InChi Code
    InChI=1S/C17H22O2/c1-10(2)13-6-5-11(3)7-14(13)17-15(18)8-12(4)9-16(17)19/h7-9,13-14,18-19H,1,5-6H2,2-4H3/t13-,14+/m0/s1
    InChi Key
    GKVOVXWEBSQJPA-UONOGXRCSA-N
    Shipping & Storage Information
    Storage
    -20°C
    Shipping
    Wet ice in continental US; may vary elsewhere
    Stability
    ≥ 1 year